![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 50, 35400-35406, December 10, 1999
From the Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
The rat hepatic asialoglycoprotein receptor
mediates clearance of galactose- and
N-acetylgalactosamine-terminated glycoproteins by
endocytosis, binding ligands through a C-type,
Ca2+-dependent carbohydrate-recognition domain
(CRD) at extracellular pH and releasing them at lower pH in endosomes.
At physiological Ca2+ concentrations, the midpoint for
ligand release from the CRD of the major subunit of the receptor is pH
7.1. In contrast, the midpoint is pH 5.0 for a galactose-binding
derivative of the homologous C-type CRD of serum mannose-binding
protein, which would thus not efficiently release ligand at an
endosomal pH of 5.4. Site-directed mutagenesis of the CRD from the
major subunit of the asialoglycoprotein receptor has been used to
identify residues that are essential for efficient release of ligand at
endosomal pH. The effects of changes to residues His256,
Asp266, and Arg270 singly and in combination
indicate that these residues reduce the affinity of the CRD for
Ca2+, so that ligands are released at physiological
Ca2+ concentrations. The proximity of these three residues
to the ligand-binding site at Ca2+ site 2 of the domain
suggests that they form a pH-sensitive switch for Ca2+ and
ligand binding. Introduction of histidine and aspartic acid residues
into the mannose-binding protein CRD at positions equivalent to
His256 and Asp266 raises the pH for
half-maximal binding of ligand to 6.1. The results, as well as sequence
comparisons with other C-type CRDs, confirm the importance of these
residues in conferring appropriate pH dependence in this family of domains.
The asialoglycoprotein receptor, which mediates clearance of
galactose or N-acetylgalactosamine-terminated glycoproteins
from circulation, is a prototype for receptor-mediated endocytosis. Related but distinct forms of the receptor are found in mammalian liver
and in peritoneal macrophages (1, 2). The rat hepatic receptor is
composed of three subunits, of which the major subunit, rat hepatic
lectin 1 (RHL-1),1 represents
70-80% of the total mass of the receptor. The second subunit,
RHL-2/3, consists of two species that are differentially glycosylated
forms of a second, homologous polypeptide (3). RHL-1 and RHL-2/3 bind
carbohydrate ligands through COOH-terminal, Ca2+-dependent carbohydrate-recognition domains
(C-type CRDs).
Structural analysis of wild-type and mutant forms of the homologous
C-type CRD from serum mannose-binding protein suggests that
carbohydrate ligands bind to the CRDs of RHL-1 at a conserved Ca2+ designated site 2. The primary interaction with sugar
is through hydroxyl groups that form coordination bonds with the
Ca2+ and hydrogen bonds with protein side chains that also
ligate the Ca2+ (4). The molecular basis for galactose
binding to C-type CRDs has been particularly well investigated in a
mutant CRD from serum mannose-binding protein which has been engineered
to bind galactose. Three single amino acid replacements (E185Q, N187D,
and H189W) and insertion of a glycine-rich loop result in a modified
CRD designated QPDWG, which has affinity and selectivity similar to RHL-1 (5). The crystal structures of this modified CRD and of a further
mutant that binds N-acetylgalactosamine with high affinity
have been solved (6, 7). These structures provide a basis for modeling
the CRD of RHL-1.
Following binding of ligand to the asialoglycoprotein receptor at the
cell surface, the receptor-ligand complex is endocytosed via
clathrin-coated pits and directed to endosomes, where the complex
dissociates. The carbohydrate ligand is targeted for degradation in
lysosomes while the receptor recycles to the cell surface with a vacant
binding site (1). Because the RHL-1 subunit alone can perform
receptor-mediated endocytosis (8), it provides a useful tool for
analyzing the molecular basis for the endocytosis process. Endosomal pH
is an important determinant of recycling of the asialoglycoprotein
receptor as well as other endocytic receptors (9). The dissociation
process that occurs in endosomes can be mimicked in vitro by
ligand release at pH 5.4. In the case of the chicken hepatic lectin, an
homologous endocytic receptor, pH modulates structural transitions
between several distinct states of the CRD (10). At endosomal pH, the
structural change causes an approximately 10-fold reduction in affinity
for Ca2+ with concomitant loss of ligand binding activity.
Although these studies provide insight into the effect of pH on ligand
binding activity and receptor conformation, they do not address the
identity of the amino acids that sense the environmental pH.
The results of site-directed mutagenesis reported here identify three
residues, including a histidine conserved in other endocytic receptors,
that determine the pH dependence of ligand binding to RHL-1. Loss of
ligand binding activity at low pH is closely correlated with decreased
affinity for Ca2+.
Materials--
Restriction enzymes were purchased from New
England BioLabs. Gal34-BSA was obtained from E-Y
Laboratories and was iodinated by the chloramine-T method (11).
Na125I was purchased from Amersham Pharmacia Biotech.
Galactose-Sepharose was prepared by the divinyl sulfone method (12).
Immulon-4 polystyrene wells were from Dynex Technologies. DNA
sequencing was performed using the Sequenase II kit from Amersham
Pharmacia Biotech.
Mutagenesis--
Mutagenesis was performed by insertion of
double-stranded synthetic oligonucleotides (GenoSys and Applied
Biosystems, United Kingdom) at appropriate restriction sites of a
cDNA for RHL-1 as described previously (13). For expression, mutant
constructs of RHL-1 were transferred to the pT5T vector (14) and
transformed into Escherichia coli strain C41(DE3), a
modified version of strain BL21(DE3) (15). Procedures for the
mutagenesis of a cDNA for rat mannose-binding protein and
construction of modified expression vectors have been described
(16).
Protein Production--
Mutant versions of QPDWG were produced
and isolated as described previously (17). Mutant versions of RHL-1
were prepared as described in Ref. 13, except that RHL-1 CRD production
was induced in the transformed C41(DE3) strain with a final
concentration of 0.7 mM
isopropyl- Solid Phase Binding Assays--
Each assay was performed in
duplicate at least twice. Ca2+-free BSA and incubation
buffer were prepared by filtration through Chelex ion-exchange syringe
filters (Bio-Rad). For the pH dependence assay, Immulon-4 wells were
coated with protein and incubated at 4 °C overnight. After the
protein solution was removed, the wells were rinsed twice with cold
loading buffer (1.25 M NaCl, 25 mM Tris-Cl, pH
7.8, 25 CaCl2) and blocked with 5% BSA in loading buffer
for 2 h at 4 °C. The wells were rinsed twice with cold 1.25 mM NaCl, incubated for 10 min at 4 °C in the same
solution and then rinsed a third time. Aliquots (50 µl) of
125I-Gal34-BSA (1 µg/ml) in 2 × incubation buffer (10 mM NaCl, 2 mM
CaCl2, 0.5% BSA) were mixed with equal volumes of 2 × pH buffer (50 mM sodium acetate in the pH 4.5-6.5
range, 50 mM MES in the pH 6-7.5 range, and 50 mM Tris-Cl in the pH 6-8 range, with all solutions
containing 2.5 M NaCl and 4% BSA) and transferred to the
Immulon-4 wells. Incubation was for 2 h at 4 °C, which was sufficient to achieve equilibrium binding. The wells were emptied, rinsed three times with cold high-Ca2+ loading buffer (1.25 M NaCl, 25 mM Tris-Cl, pH 7.8, 250 mM CaCl2), dried, and counted in a Wallac
Wizard 1470
For the determination of Ca2+ dependence of neoglycoprotein
ligand binding, Immulon-4 wells were coated with protein and incubated at 4 °C overnight. One set of wells was prepared as described above
and rinsed twice with cold high pH Ca2+-free rinse buffer
(1.25 M NaCl, 25 mM Tris-Cl, pH 7.8) and a duplicate set of wells was rinsed with low pH Ca2+-free
rinse buffer (1.25 M NaCl, 25 mM sodium
acetate, pH 5.4). All wells were incubated for 10 min at 4 °C and
then rinsed a third time in the appropriate Ca2+-free rinse
buffer. Aliquots (50 µl) of 125I-Gal34-BSA (1 µg/ml) in high pH, Ca2+-free incubation buffer (1.25 M NaCl, 25 mM Tris-Cl, pH 7.8, 5% BSA) or in
low pH, Ca2+-free incubation buffer (1.25 M
NaCl, 25 mM sodium acetate, pH 5.4, 5% BSA) were added to
equal volumes of serial 3:2 dilutions of CaCl2 and then
transferred to the appropriate Immulon-4 wells. Incubation was for
2 h at 4 °C. The wells were emptied, rinsed three times with
cold high-Ca2+ loading buffer, dried, and counted as above.
Fluorescence Measurements--
Measurements were performed on a
Jasco FP777 fluorescence spectrophotometer with a 170 W lamp using a
1-cm square quartz cuvette. Emission spectra were recorded for 30 s using excitation at 295 nm (10 nm slit width) and measuring emission
at 340 nm (5 nm slit width). For the determination of Ca2+
affinity, aliquots of CaCl2 were added to tubes containing
1.5 ml of a 1 µM protein solution in 50 mM
sodium acetate, pH 5.5-6.2, 50 mM MES, pH 6.2-7.5, or 50 mM Tris-HCl, pH 6.7-7.8, with all solutions containing 100 mM NaCl. All buffers were made with distilled water passed
over a Chelex-100 column. The tubes were allowed to equilibrate at
37 °C and the temperature of the measurements was maintained at
37 °C. Background intensity in samples without protein was
subtracted from the measurements.
Data Analysis--
Using a nonlinear least-squares fitting
program (SigmaPlot, Jandel Scientific), data from the pH dependence
assay were fitted to Equation 1,
Molecular Modeling--
The coordinates of QPDWG modified to
contain histidine at residue 202 (7) were used for modeling RHL-1.
Residues from the RHL-1 sequence were inserted at corresponding
positions using the standard rotomer library in Insight II (BioSym). No
attempt was made to minimize the structure.
pH-dependent Binding of Ligands to C-type CRDs--
A
solid-phase binding assay was used to analyze the pH dependence of
ligand binding to the isolated CRD of RHL-1 (Fig.
1). At a Ca2+ concentration
near to that found in extracellular fluids (1 mM), ligand
binding to the isolated CRD decreases as the pH goes from extracellular, pH 7.3, to endosomal, pH 5.4. The pattern of binding is
similar to that of the intact receptor (18), indicating that residues
which confer pH sensitivity are located within the CRD portion of
RHL-1. In contrast, QPDWG, the galactose-binding mutant CRD derived
from serum mannose-binding protein, shows substantially less change in
ligand binding over the pH range 7.3 to 5.4, although ligand binding
activity is lost at lower pH values. Similar behavior is observed for
unmodified serum mannose-binding protein, which is not directly
involved in receptor-mediated endocytosis and therefore does not
require the ability to release ligand at endosomal pH (data not shown).
Points of half-maximal ligand binding, designated pHB, are
7.1 ± 0.1 for the CRD from RHL-1 and 5.0 ± 0.3 for QPDWG (averages for three different experiments).
The CRDs of QPDWG and RHL-1 are 31% identical in overall amino acid
sequence and are based on the same protein fold (5). The difference in
the behavior of these two CRDs suggests that pH sensitivity of ligand
binding in the range between pH 5.4 and 7.3 is conferred by specific
amino acid residues found in RHL-1 but not in QPDWG. Side chains that
might be involved in establishing the appropriate pH sensitivity for
cycles of ligand binding and release during endocytosis were
highlighted by comparing the amino acid sequence of RHL-1 to the
sequences of QPDWG and two other C-type lectins that have
pH-dependent ligand-binding profiles similar to RHL-1: the
chicken hepatic lectin (10) and the macrophage asialoglycoprotein
receptor (pHB of
6.3).2
On the assumption that pH sensitivity of ligand binding results from
the interaction of protons with amino acid side chains, candidate
residues for controlling pH sensitivity in RHL-1 were identified as
residues conserved in the macrophage asialoglycoprotein receptor but
not found in QPDWG. Comparison of the sequences shown in Fig.
2 reveals nine potentially protonatable
residues that meet this criterion.
Mutations in RHL-1 That Alter pH Sensitivity--
As an initial
test of the role of specific residues in defining pH dependence of
ligand binding to RHL-1, each of the nine residues identified in the
preceding section was changed to a non-dissociating amino acid of a
similar size. Changing Arg273 to a leucine residue results
in a CRD that can no longer be purified by affinity chromatography on
galactose-Sepharose, suggesting that this mutation causes misfolding of
the domain. The remaining eight mutants containing single site changes
could be purified on galactose-Sepharose, indicating that the basic
fold of the CRD is unaffected by these mutations. In the solid-phase
binding assay, five of the mutants, with changes at positions
His203, Asp224, Asp227,
Glu229, and Asp260, have profiles
indistinguishable from wild-type (Table
I), suggesting that side chains of these
residues are unlikely to play a role in establishing pH sensitivity of
ligand binding.
Of the three single site mutations that do alter pH dependence of
ligand binding, two cause a decrease in the pHB value.
Representative results for mutants H256Q and D266N are shown in Fig.
3A. For both of these mutants,
the pH that supports half-maximal ligand binding is approximately 1 unit lower than for wild-type CRD. The pH profile and pHB
value for a double mutant containing both of these changes are very
similar to those of the single mutants, indicating that
His256 and Asp266 do not function in an
additive fashion. The ability of the singly and doubly mutant CRDs to
maintain ligand binding at endosomal pH also suggests that the role of
His256 and Asp266 is to destabilize the CRD so
that physiological release of ligand can take place.
A model for RHL-1 was generated based on the crystal structure of the
CRD from a previously described variant of QPDWG that contains the
histidine corresponding to His256 in RHL-1. Insertion of
the additional RHL-1 side chains that have been mutated reveals that
the five residues which appear not to be involved in establishing pH
dependence of ligand binding are at least 16 Å distant from the
sugar-binding site adjacent to Ca2+ site 2. In contrast,
His256 and Asp266 are predicted to lie within 7 Å of this Ca2+ (Fig. 4). The
fact that the His256 and Asp266 side chains are
close to each other is consistent with the idea that they work together
to affect pH dependence and thus that mutations at these positions
produce similar and non-additive effects. The proximity of these side
chains to the sugar-binding site suggests that partial protonation of
one of these residues might have a direct, local effect on the binding
site, causing loss of ligand binding activity.
The remaining single mutant that displays a change in the pH dependence
profile is R270L, for which the pHB is shifted to a higher
value. This change is accompanied by a substantial loss in affinity for
Ca2+, so pH dependence was measured in the presence of 5 mM Ca2+ (Fig. 3B). Mutation of the
adjacent residue Arg269 to leucine results in essentially
no change in pH dependence of ligand binding, suggesting that the
effect of the Arg270 mutation results from a specific
effect of this arginine side chain. Combination of the H256Q and D266N
mutations with the R270L change results in partial compensation between
the shifts seen with the separate mutations (Table I). The loss in
absolute affinity for Ca2+ makes it difficult to interpret
the effects of the change at position 270. However, as shown in Fig. 4,
the arginine side chain is likely to be positioned close to
His256 and Asp266 and within 8 Å of
Ca2+ site 2. It thus forms part of a cluster of amino acid
side chains that affect pH sensitivity.
Modulation of Ligand Binding by Ca2+--
It has
previously been demonstrated that pH-dependent binding of
saccharide ligands to the chicken hepatic lectin is correlated with
pH-dependent changes in affinity of the C-type CRD for
Ca2+ (10). The ability to generate mutant domains with
altered pH dependence makes it possible to examine the relationship
between pH and Ca2+ binding in more detail. As a starting
point, the Ca2+ dependence of galactose-BSA binding to the
wild-type CRD of RHL-1 and to QPDWG at high and low pH values are
compared in Fig. 5. In all cases, binding
is dependent on the second power of the concentration of
Ca2+, reflecting the presence of two Ca2+ sites
in the CRD (10). The Ca2+ dependence can be characterized
by an apparent KCa, which represent the
Ca2+ concentration that supports half-maximal ligand
binding. Like the chicken hepatic lectin, RHL-1 shows substantially
reduced affinity for Ca2+ at endosomal pH. In contrast,
QPDWG is relatively insensitive to a reduction in pH from 7.8 to
5.4.
The relationship between KCa and pH over this
range is demonstrated in greater detail for RHL-1 in Fig.
6. The value of log KCa shows an approximately linear dependence on
pH. The point at which this line crosses the physiological
Ca2+ concentration range represents the pH at which
half-maximal binding of ligand will be achieved and thus corresponds to
the pHB value. The behavior of the H256Q/D266N mutant of
RHL-1 contrasts with the wild-type in that KCa
values at all pH values are lower. This shift has the effect of
reducing the pH for half-maximal binding at physiological pH. For the
receptor to function during endocytosis, the position of the
line in Fig. 6 must be such that it passes through the
physiological Ca2+ concentration range between the pH value
at the cell surface and the value in endosomes. As noted above, the
effect of His256 and Asp266 is to decrease
affinity for Ca2+ over the entire pH range.
While it was not practical to measure KCa values
at all pH values for all of the mutant CRDs, the approximately linear
relationship between pH and log KCa makes it
possible to gain an appreciation for the effects of the mutations by
measuring KCa at the two extreme pH values of
5.4 and 7.8. A compilation of such values for various mutant CRDs from
RHL-1 is presented in Table I. The results confirm that decreases in
pHB are accompanied by an overall increase in apparent
affinity for Ca2+ throughout the pH range and that
increases in pHB are correlated with weaker binding of
Ca2+. Thus, the effect of the mutations that decrease the
pHB is to increase Ca2+ affinity so that the
domain continues to bind ligand at physiological Ca2+ concentrations.
Mutations in QPDWG Designed to Alter pH Sensitivity--
The roles
of residues His256, Asp260, and
Asp266 in RHL were further investigated by incorporating
these amino acids at equivalent positions into the relatively pH
insensitive CRD of QPDWG. The results, which are summarized in Table
II, confirm the ability of
His256 to raise pHB. Incorporation of this
residue into QPDWG increases the pHB by more than half of a
pH unit. In contrast, incorporation of residues equivalent to
Asp260 or Asp266 alone has no significant
effect on pHB, although there is a slight increase in
pHB when these residues are incorporated in the presence of
the histidine residue. Although these effects are largely consistent with the results for RHL-1, the highest pHB obtained, in
the presence of both His256 and Asp266, is
still roughly one pH unit lower than for wild-type RHL.
The effect of pH on KCa was also investigated
for the QPDWG mutants, since changes on Ca2+ affinity
provide a means of determining how accurately these mutants mimic the
behavior of a CRD involved in endocytosis. As shown in Table II, the
KCa of QPDWG determined from the
Ca2+ dependence of neoglycoprotein binding is relatively
insensitive to pH, as it changes by a factor of roughly 2.5 over the
range of 5.4 to 7.8. These results suggest that shifts in the
pHB values either up or down are not related to large
changes in the relative KCa values at pH 5.4 and
7.8, but represent an overall loss of affinity for Ca2+ at
all pH values.
This interpretation was verified in direct measurements of
Ca2+ binding, which can be monitored in mannose-binding
protein and derivatives by following changes in intrinsic fluorescence
(20). Results for QPDWG and the mutant with the highest measured
pHB are shown in Fig. 7. As
noted in previous experiments with wild-type mannose-binding proteins,
the absolute KCa values measured by this
technique differ from those determined indirectly in the neoglycoprotein-binding assay, probably because of the effect of the
bound sugar. Nevertheless, this approach provides a convenient way to
compare affinity for Ca2+ over a range of pH values. The
results shown in Fig. 7 confirm that the mutations introduced into
QPDWG result in an overall decrease in affinity for Ca2+ at
all pH values without substantially changing the relative affinity at
low and high pH, which would correspond to increased slope in a plot of
KCa as a function of pH. Thus, even the mutant containing residues corresponding to His256 and
Asp266, which has the highest pHB value at 1 mM Ca2+, differs substantially from RHL-1 in
its Ca2+-binding properties.
In an attempt to make the behavior of QPDWG more like RHL, similar
experiments were undertaken investigating the contribution of residues
Arg270 and Arg273. The presence of a proline
residue adjacent to Arg270 in RHL-1 suggests that the local
conformation of the polypeptide may differ substantially from QPDWG.
For this reason, all three amino acid residues predicted to be in this
loop (Arg-Pro-Tyr) were incorporated into QPDWG at positions 216-218.
As indicated in Table II, this change by itself or in the presence of
His256 alters the pHB only slightly when
measured at 1 mM Ca2+. However, the slight
compensatory relationship between the His256 and
Arg270 positions is amplified at 4 mM
Ca2+. These results are again consistent with the findings
for RHL, in which removal of arginine at position 270 causes an
increase in pHB, since in QPDWG incorporation of the
arginine residue decreases the pHB. In contrast, in the
presence of both Asp266 and His256, this
arginine actually increases the pHB. However, this triple mutant shows substantially reduced affinity for Ca2+, again
suggesting that changes in this region may result in significant rearrangement of the Ca2+-binding sites. Similarly, mutants
of QPDWG containing arginine at the position corresponding to
Arg273 of RHL-1 display greatly decreased affinity for
Ca2+, which could not be quantified using the solid-phase
binding assay.
A further important difference between RHL and QPDWG is the arrangement
of ligands for the accessory Ca2+ site (site 1). As noted
in Fig. 2, at least one of the site 1 ligands, at position 217 in RHL,
must be different from QPDWG and two adjacent residues are absent from
RHL. The effect of inserting the shorter loop corresponding to residues
216-219 of RHL, replacing residues 157-168 of QPDWG, was tested by
the creation of two additional mutations, resulting in a dramatic loss
in affinity for Ca2+ and a concomitant increase in the
apparent pHB (Table II). These results suggest that the
arrangement of Ca2+ site 1 ligands may contribute to
establishing the appropriate affinity for Ca2+ and the
pHB of RHL. However, the data also indicate that mutants containing the modified site 1 do not attain all of the
Ca2+-binding characteristics of RHL.
The results reported here provide strong evidence linking pH
sensitivity of ligand binding to C-type CRDs with
pH-dependent changes in Ca2+ affinity. The
presence of a cluster of titratable amino acid side chains near the
ligand-binding site at Ca2+ site 2 in RHL-1 suggests that
control of binding by pH is probably mediated at least in part by this
set of side chains acting as a pH sensor. The pH sensitivity of the
domain is ultimately a result of the summed effect of multiple
titratable groups in the domain. However, many potentially titratable
groups on the surface of the protein can be mutated without affecting
the pH dependence of ligand binding to the CRD from RHL-1, indicating
that loss of binding activity in the physiological pH range is a result of a local event involving relatively few amino acid side chains.
One scenario consistent with the evidence is that the protonation state
of the histidine side chain at position 256 determines the affinity for
Ca2+ binding at site 2, perhaps because it makes direct
hydrogen bond interactions with certain of the Ca2+ site 2 ligands. The exact interactions of this histidine residue in the QPDWG
model background are known to vary depending on the presence of other
side chains in this region (7), so it is not yet possible to propose a
specific mechanism for linking the pH sensor to Ca2+ site
2. However, it is possible that a hydrogen bond forms between His256 and one of the site 2 Ca2+ ligands,
corresponding to Asn264 (Fig. 4), so that protonation of
the imidazole group would directly affect the position of the amide
group and thus alter affinity for Ca2+. In any case, the
divergent effects of changing residues Asp266 and
Arg270 could result from the influence of these side chains
on the pKa of His256. The presence of an
aspartate side chain would reduce the pKa of the
imidazole group while the arginine side chain would increase the
pKa.
Even in the absence of His256, ligand binding activity of
the CRD from RHL-1 is lost at low pH (below 5.4). This loss of
activity, under nonphysiological conditions, may reflect more general
unfolding of the domain as multiple aspartate and glutamate side chains start to become protonated. This interpretation suggests that the
increased steepness of the pH curves at low pH values (Fig. 3) reflects
the involvement of multiple protons in bringing about this unfolding.
It is also possible that carboxylate coordination ligands for the two
Ca2+ become sufficiently protonated at this pH to result in
release of Ca2+ and hence loss of ligand binding activity.
Examination of the CRDs from multiple C-type lectins with differing pH
profiles provides additional evidence for the importance of the residue
corresponding to His256 in establishing pH sensitivity in
the physiological pH range. Although the CRD of RHL-2/3, the minor
subunit of the hepatic asialoglycoprotein receptor, is 59% identical
to RHL-1, it binds Ca2+ more weakly and does not show a
loss of affinity as the pH decreases from 7.8 to 5.4. Interestingly,
this subunit differs at positions corresponding to His256,
Asp266, and Arg270 (Fig. 2). These residues are
also absent from almost all other CRDs in the C-type lectin family,
which correlates with the fact that most of these proteins are not
known to undergo pH-dependent release of ligand under
physiological conditions.
CRDs that do contain a histidine side chain at the position
corresponding to His256 of RHL-1 include the chicken
hepatic lectin and the macrophage asialoglycoprotein receptor. The pH
dependence of ligand binding to the chicken hepatic lectin is closely
similar to RHL-1, although the amino acid residues corresponding to
Asp266 and Arg270 are not conserved (Fig. 2),
suggesting that, while the histidine side chain may remain the primary
pH sensor, the effective pKa of this side chain is
established in different ways. The absence of the critical histidine
residue from the primary ligand-binding CRD of the macrophage mannose
receptor (CRD-4) correlates with the fact that ligand release from this
CRD occurs at lower pH than from RHL-1 (21).
Other endocytic receptors share with the C-type lectins the
presence of divalent cations at critical sites in the ligand-binding domains. The Mn2+ residue that forms part of the
ligand-binding site in the cation-dependent mannose
6-phosphate receptor is in close proximity to a histidine residue that
has been suggested as a possible pH-dependent regulator of
sugar binding (22). Many other endocytic receptors, such as the low
density lipoprotein receptor, contain homologous complement-like repeats that are folded around a Ca2+. Several of these
domains have been characterized structurally and it has been suggested
that loss of ligand binding activity at endosomal pH may be mediated by
release of the Ca2+ (23). However, examination of the
sequences of the Ca2+-containing complement-like repeats
fails to reveal a conserved histidine residue near to the
Ca2+ site. In different receptors, other mechanisms must be
responsible for determining the pH-sensitive changes in ligand binding
activity that are essential to the endocytic processes. In addition,
the concentration of Ca2+ in endosomes appears to be
reduced compared with the extracellular environment, providing an
alternative route to destabilization of
Ca2+-dependent receptor-ligand complexes
(24).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactoside when the cells had grown to
OD600 of 0.6. For fluorescence measurements, the mutant
versions of QPDWG were further dialyzed to ensure the absence of
Ca2+. The proteins were dialyzed at 4 °C against three
changes of 500 ml of 50 mM Tris-Cl, pH 7.8, 100 mM NaCl made with distilled water from which metal ions had
been removed by passage over a Chelex-100 column.
-counter.
where pHB is the pH value at which half-maximal
binding is observed. Data from the Ca2+ affinity binding
assays and the fluorescence experiments were fitted to Equation 2,
(Eq. 1)
(Eq. 2)
where KCa is the concentration of
Ca2+ at which half-maximal binding is observed. Values
reported are the mean ± S.D. for at least two assays. Binding
experiments were each performed in duplicate.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
pH dependence of ligand binding to the CRDs
from RHL-1 and QPDWG. The assay was performed in the presence of 1 mM CaCl2. Open and closed
symbols represent data obtained in different buffer systems: 25 mM sodium acetate in the pH 4.5-6.5 range, 25 mM MES in the pH 6-7.5 range, and 25 mM
Tris-Cl in the pH 6-9 range.

View larger version (27K):
[in a new window]
Fig. 2.
Aligned amino acid sequences from CRDs of
RHL-1 and other C-type lectins. Regions of secondary structure in
QPDWG are indicated above the sequence. L denotes
loop, S denotes
-strand, and H denotes
-helix. Residues coordinating the two Ca2+ are denoted
1 and 2 above the sequence. The numbering
corresponds to the RHL-1 sequence. Amino acids with potentially
titratable side chains that are present in RHL-1 and the macrophage
asialoglycoprotein receptor (RHL-M) but not in QPDWG are
shaded. Positions at which amino acids from RHL-1 were
introduced into QPDWG are boxed. Residues in QPDWG that have
been replaced are 157-162 (EVTEGQ), 202 (Thr), 212 (Ile), and 216-218
(ASH). Within this region, the macrophage asialoglycoprotein receptor
shows 78% sequence identity with RHL-1, while the chicken hepatic
lectin (CHL) is more distantly related (42% sequence
identity).
pH values at half-maximal binding (pHB) and Ca2+
dependence of ligand binding for RHL-1 wild-type and mutant CRDs

View larger version (25K):
[in a new window]
Fig. 3.
pH dependence of ligand binding to wild-type
and mutant forms of the CRD of RHL-1. Open and
closed symbols represent data obtained in different buffer
systems as described in the legend to Fig. 1. A, wild-type
(circles), H256Q (squares), D266N (up
triangles), H256Q/D266N (down triangles). B,
wild-type (circles), R270L (octagons),
H256Q/D266N/R270L (diamonds).

View larger version (33K):
[in a new window]
Fig. 4.
Molecular model of RHL-1 showing the
predicted positions of residues tested for involvement in determining
pH dependence of ligand binding. The model was constructed based
on the x-ray crystal structure of QPDWG mutant T202H complexed with
N-acetylgalactosamine (Protein Data Bank code 1BCH). Carbon
atoms are shaded black, oxygen white, and
nitrogen gray. Large black sphere represents
Ca2+. Four side chains, including Asn264, that
form axial coordination bonds to Ca2+ 2 (dotted
lined) are shown. These four residues also form hydrogen bonds
with the bound sugar ligand, which would be located above the plane of
the page, directly above the Ca2+. Side chains
of residues that alter the pH dependence of the CRD are also shown. The
distance between Asn264 and His256, indicated
by the dashed line, is 2.97 Å. This figure was prepared
with Molscript (19).

View larger version (23K):
[in a new window]
Fig. 5.
Ca2+ dependence of
125I-Gal-BSA binding to the wild-type CRD of RHL-1 and to
QPDWG. Data were fitted to a second-order equation as shown by the
solid lines. The buffers used were 25 mM
Tris-HCl, pH 7.8 (closed symbols), and 25 mM
sodium acetate, pH 5.4 (open symbols). A,
wild-type RHL-I. B, QPDWG.

View larger version (25K):
[in a new window]
Fig. 6.
pH dependence of apparent Ca2+
affinity for wild-type and mutant CRD of RHL-1.
KCa values were derived from neoglycoprotein
binding experiments as shown in Fig. 5 using three different sets of
buffers as indicated in Fig. 1. Lines were fitted to the
data based on the approximately linear relationship between log
KCa and pH. Shaded band represents
the physiological Ca2+ concentration range.
pH values at half-maximal binding (pHB) and Ca2+
dependence of ligand binding for QPDWG and further mutant CRDs from
serum mannose-binding protein

View larger version (24K):
[in a new window]
Fig. 7.
pH dependence of Ca2+ affinity
for QPDWG and mutant QPDWGHD. KCa values
were derived from fluorescence measurements, using three different sets
of buffers as indicated in Fig. 1. QPDWG+HD denotes QPDWG
containing histidine and aspartic acid at positions corresponding to
His256 and Asp266 of RHL-1. Lines
were fitted to the data based on the approximately linear relationship
between log KCa and pH. Shaded band
represents the physiological Ca2+ concentration
range.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ken Ng and Bill Weis for help with the fluorescence experiments.
| |
FOOTNOTES |
|---|
* This work was supported by Grants 041845 and 054508 from the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Wellcome Principal Research Fellow. To whom all correspondence
should be addressed: Dept. of Biochemistry, University of Oxford, South
Parks Rd., Oxford OX1 3QU, United Kingdom. Tel.: 44-1865-275727; Fax:
44-1865-275339; E-mail: kd@glycob.ox.ac.uk.
2 H. Dobbyn and S. Wragg, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RHL, rat hepatic lectin; CRD, carbohydrate-recognition domain; QPDWG, galactose-binding variant of the CRD from rat serum mannose-binding protein; BSA, bovine serum albumin; MES, 4-morpholineethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Spiess, M. (1990) Biochemistry 29, 10008-10019 |
| 2. |
Li, M.,
Kurata, H.,
Itoh, N.,
Yamashina, I.,
and Kawasaki, T.
(1990)
J. Biol. Chem.
265,
11295-11298 |
| 3. |
Halberg, D. F.,
Wager, R. E.,
Farrell, D. C.,
Hildreth, J., IV,
Quesenberry, M. S.,
Loeb, J. A.,
Holland, E. C.,
and Drickamer, K.
(1987)
J. Biol. Chem.
262,
9828-9838 |
| 4. | Weis, W. I., Drickamer, K., and Hendrickson, W. A. (1992) Nature 360, 127-134[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Iobst, S. T.,
and Drickamer, K.
(1994)
J. Biol. Chem.
269,
15512-15519 |
| 6. |
Kolatkar, A.,
and Weis, W. I.
(1996)
J. Biol. Chem.
271,
6679-6685 |
| 7. |
Kolatkar, A. R.,
Leung, A. K.,
Isecke, R.,
Brossmer, R.,
Drickamer, K.,
and Weis, W. I.
(1998)
J. Biol. Chem.
273,
19502-19508 |
| 8. |
Braiterman, L. T.,
Chance, S. C.,
Porter, W. R.,
Lee, Y. C.,
Townsend, R. R.,
and Hubbard, A. L.
(1989)
J. Biol. Chem.
264,
1682-1688 |
| 9. | Mellman, I., Fuchs, R., and Helenius, A. (1986) Annu. Rev. Biochem. 55, 663-700[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Loeb, J. A.,
and Drickamer, K.
(1988)
J. Biol. Chem.
263,
9752-9760 |
| 11. | Greenwood, F. C., Hunter, W. M., and Glover, J. S. (1963) Biochem. J. 89, 114-123[Medline] [Order article via Infotrieve] |
| 12. | Fornstedt, N., and Porath, J. (1975) FEBS Lett. 57, 187-191[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Iobst, S. T.,
and Drickamer, K.
(1996)
J. Biol. Chem.
271,
6686-6693 |
| 14. | Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., and Thompson, R. C. (1990) Nature 343, 341-346[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Miroux, B., and Walker, J. E. (1996) J. Mol. Biol. 260, 289-298[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Iobst, S. T.,
Wormald, M. R.,
Weis, W. I.,
Dwek, R. A.,
and Drickamer, K.
(1994)
J. Biol. Chem.
269,
15505-15511 |
| 17. |
Weis, W. I.,
Crichlow, G. V.,
Murthy, H. M. K.,
Hendrickson, W. A.,
and Drickamer, K.
(1991)
J. Biol. Chem.
266,
20678-20686 |
| 18. |
Hudgin, R. L.,
Price, W. E., Jr.,
Ashwell, G.,
Stockert, R. J.,
and Morell, A. G.
(1974)
J. Biol. Chem.
249,
5536-5543 |
| 19. | Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef] |
| 20. | Ng, K. K.-S., and Weis, W. I. (1998) Biochemistry 37, 17977-17989[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Mullin, N. P.,
Hall, K. T.,
and Taylor, M. E.
(1994)
J. Biol. Chem.
269,
28405-28413 |
| 22. | Roberts, D. L., Weix, D. J., Dahms, N. M., and Kim, J.-J. P. (1998) Cell 93, 639-648[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Domer, K., Huang, W., and Gettins, P. G. W. (1998) Biochemistry 37, 17016-17023[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Gerasimenko, J. V., Tepikin, A. V., Petersen, O. H., and Gerasimenko, O. V. (1998) Curr. Biol. 8, 1335-1338[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
A. S. Powlesland, T. Fisch, M. E. Taylor, D. F. Smith, B. Tissot, A. Dell, S. Pohlmann, and K. Drickamer A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Truncated Glycans J. Biol. Chem., January 4, 2008; 283(1): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Garlatti, L. Martin, E. Gout, J.-B. Reiser, T. Fujita, G. J. Arlaud, N. M. Thielens, and C. Gaboriaud Structural Basis for Innate Immune Sensing by M-ficolin and Its Control by a pH-dependent Conformational Switch J. Biol. Chem., December 7, 2007; 282(49): 35814 - 35820. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ward, N. S. Stambach, K. Drickamer, and M. E. Taylor Polymorphisms in Human Langerin Affect Stability and Sugar Binding Activity J. Biol. Chem., June 2, 2006; 281(22): 15450 - 15456. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Coombs, S. A. Graham, K. Drickamer, and M. E. Taylor Selective Binding of the Scavenger Receptor C-type Lectin to Lewisx Trisaccharide and Related Glycan Ligands J. Biol. Chem., June 17, 2005; 280(24): 22993 - 22999. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Gange, J. M. W. Quinn, H. Zhou, V. Kartsogiannis, M. T. Gillespie, and K. W. Ng Characterization of Sugar Binding by Osteoclast Inhibitory Lectin J. Biol. Chem., July 9, 2004; 279(28): 29043 - 29049. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Appenzeller-Herzog, A.-C. Roche, O. Nufer, and H.-P. Hauri pH-induced Conversion of the Transport Lectin ERGIC-53 Triggers Glycoprotein Release J. Biol. Chem., March 26, 2004; 279(13): 12943 - 12950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Fadden, O. J. Holt, and K. Drickamer Molecular characterization of the rat Kupffer cell glycoprotein receptor Glycobiology, July 1, 2003; 13(7): 529 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Stambach and M. E. Taylor Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells Glycobiology, May 1, 2003; 13(5): 401 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. East, S. Rushton, M. E. Taylor, and C. M. Isacke Characterization of Sugar Binding by the Mannose Receptor Family Member, Endo180 J. Biol. Chem., December 20, 2002; 277(52): 50469 - 50475. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer Structure of the LDL Receptor Extracellular Domain at Endosomal pH Science, December 20, 2002; 298(5602): 2353 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuiji, M. Fujimori, Y. Ohashi, N. Higashi, T. M. Onami, S. M. Hedrick, and T. Irimura Molecular Cloning and Characterization of a Novel Mouse Macrophage C-type Lectin, mMGL2, Which Has a Distinct Carbohydrate Specificity from mMGL1 J. Biol. Chem., August 2, 2002; 277(32): 28892 - 28901. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feinberg, S. Park-Snyder, A. R. Kolatkar, C. T. Heise, M. E. Taylor, and W. I. Weis Structure of a C-type Carbohydrate Recognition Domain from the Macrophage Mannose Receptor J. Biol. Chem., July 7, 2000; 275(28): 21539 - 21548. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feinberg, D. Torgersen, K. Drickamer, and W. I. Weis Mechanism of pH-dependent N-Acetylgalactosamine Binding by a Functional Mimic of the Hepatocyte Asialoglycoprotein Receptor J. Biol. Chem., November 3, 2000; 275(45): 35176 - 35184. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||